This article is more than 5 years old. Information may no longer be current.

VIDEO: Schroeder discusses riluzole for bone formation in patients with spinal cord injuries

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BOSTON — At the North American Spine Society Annual Meeting, Gregory D. Schroeder, MD, discussed a study that looked at the effect of riluzole on bone formation. While he said more research needs to be done regarding its impact on osteoblasts and mesenchymal stem cells, he noted the drug is promising and may lead to a decrease in secondary injuries.